D. Metzinger

发表

Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines.

D. Metzinger, Douglas D. Taylor, C. Gerçel-Taylor, 2006, Cancer letters.

Trends in Incidence and Mortality Rates of Uterine Cancer in Kentucky

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2021, Southern medical journal.

Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications

S. Rai, D. Metzinger, Jianmin Pan, 2011, Journal of gynecologic oncology.

Cervical cancer incidence and mortality rates in Kentucky.

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2020, Gynecologic oncology.

Clinical Characteristics of Patients With Prolonged Disease-Free Survival After Primary Treatment in Advanced Ovarian Cancer: A Brief Report

D. Metzinger, L. Parker, P. Ramirez, 2010, International Journal of Gynecologic Cancer.

Retraction of an intraperitoneal chemotherapy port: a case report and literature review

D. Metzinger, L. Parker, C. Helm, 2006, International Journal of Gynecologic Cancer.

Incidence of nodal metastasis in endometrioid endometrial cancer risk groups: A Gynecologic Oncology Group multicenter review

D. Metzinger, R. Coleman, L. Parker, 2011 .

Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer.

D. Metzinger, V. Suman, K. Podratz, 2005, Gynecologic oncology.

CXCR4 expression in ovarian cancer is associated with peritoneal dissemination

D. Metzinger, M. Ratajczak, R. Edwards, 2004 .

A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity.

D. Metzinger, Douglas D. Taylor, Narendra P. Singh, 2003, Cancer research.

Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?

D. Metzinger, M. El-Ghamry, P. Barry, 2021, Journal of contemporary brachytherapy.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

S. Cha, J. Sloan, D. Metzinger, 2003, Gynecologic oncology.

Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.

D. Metzinger, L. Parker, R. Edwards, 2007, Gynecologic oncology.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy

S. Cha, J. Sloan, D. Metzinger, 2003 .

Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.

D. Metzinger, L. Parker, J. Gaskins, 2016, Brachytherapy.

Clear Cell Adenocarcinoma Arising in an Adenomyoma of the Broad Ligament

D. Metzinger, L. Parker, M. Sanders, 2015, International journal of surgical pathology.

Multiple Extrauterine Adenomyomas Presenting in Upper Abdomen and Pelvis: A Case Report and Brief Review of the Literature

D. Metzinger, Mana Moghadamfalahi, 2012, Case reports in obstetrics and gynecology.

Comparison of Current Staging Systems and a Novel Staging System for Uterine Leiomyosarcoma

W. Cliby, D. Metzinger, R. Giuntoli, 2013, International Journal of Gynecologic Cancer.

Nodal Metastasis Risk in Endometrioid Endometrial Cancer

D. Metzinger, R. Coleman, L. Parker, 2012, Obstetrics and gynecology.

Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity

D. Metzinger, L. Parker, R. Edwards, 2006, International Journal of Gynecologic Cancer.

Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior.

D. Metzinger, G. Keeney, R. Giuntoli, 2007, The Journal of reproductive medicine.

Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancer.

D. Metzinger, L. Parker, J. Gaskins, 2015, Brachytherapy.

Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.

D. Metzinger, S. Atay, Ç. Gerçel-Taylor, 2010, Gynecologic oncology.

The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation.

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2020, Brachytherapy.

Modulation of microRNA associated with ovarian cancer cells by genistein.

D. Metzinger, D. Taylor, L. Parker, 2009, European journal of gynaecological oncology.

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: First Report of the HYPER-O Registry

S. Rai, D. Metzinger, D. Bartlett, 2009, International Journal of Gynecologic Cancer.

Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2021, International Journal of Gynecological Cancer.

Gynecologic Oncology Computed tomographyeplanned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity

D. Metzinger, L. Parker, J. Gaskins, 2016 .

Bilateral adnexal masses: A case report of acute myeloid leukemia presenting with myeloid sarcoma of the ovary and review of literature

D. Metzinger, S. Vranić, S. Al-Quran, 2023, Gynecologic oncology reports.

When prolapse cannot be reduced: incarcerated procidentia due to pelvic mass

D. Metzinger, Ankita Gupta, Z. Cope, 2022, International Urogynecology Journal.

SECONDARY SURGICAL CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (SSC-HIPEC) FOR RECURRENT OVARIAN AND ENDOMETRIAL CANCER

D. Metzinger, C. Helm, R. Edwards, 2004, International Journal of Gynecologic Cancer.

Successful pregnancy after uterus-sparing chemoradiation therapy for vaginal cancer.

D. Metzinger, M. El-Ghamry, N. Dunlap, 2015, Practical radiation oncology.